“…To analyse the serology data four groups ofpatients were identified, according to treatment by surgery and/or albendazole, and whether or not relapse occurred (Figures 1-4 1,5,6,7,9,11,14) Patients 1,5,7,14 received albendazole before surgery and all had similar patterns of CFT results (Figure 1). A 4-fold or greater rise in complement fiing antibodies (CFA) occurred during or within 3 months of the end of chemotherapy and was followed by subsequent fall.…”